[Experimental characteristics of the spectrum of pharmacologic activity of the tranquilizer lorazepam].
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D000927:Anticonvulsants; D001007:Anxiety / Q000187:drug effects; D002707:Chlordiazepoxide / Q000494:pharmacology; D003220:Conflict, Psychological; D003975:Diazepam / Q000494:pharmacology; D004357:Drug Synergism; D006591:Hexobarbital / Q000494:pharmacology; D006801:Humans; D006993:Hypnotics and Sedatives; D007266:Inhibition, Psychological / Q000187:drug effects; D051379:Mice; D009125:Muscle Relaxants, Central; D009538:Nicotine / Q000037:antagonists & inhibitors; D009567:Nitrazepam / Q000494:pharmacology; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D051381:Rats; D011930:Reaction Time / Q000187:drug effects
D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D006993:Hypnotics and Sedatives; D009125:Muscle Relaxants, Central; D009538:Nicotine; D002707:Chlordiazepoxide; D009567:Nitrazepam; D006591:Hexobarbital; D003975:Diazepam; D010433:Pentylenetetrazole
Eksperimental'naia kharakteristika spektra farmakologicheskoĭ aktivnosti trankvilizatora lorazepama